A considered catalog.

A once-weekly GLP-1 injection for sustained appetite regulation and metabolic support, titrated under clinical guidance.

A once-weekly dual GIP/GLP-1 injection for dual-pathway metabolic support, when clinically appropriate.

A needle-free, once-daily dissolvable GLP-1 tablet for those who prefer a daily oral dose.

A low-dose weekly semaglutide injection with lipotropic support for metabolic maintenance.

A low-dose weekly tirzepatide injection with lipotropic support for metabolic maintenance.

A low-dose weekly semaglutide injection with NAD+ and B12 for metabolic support and cellular energy.

A low-dose weekly tirzepatide injection with NAD+ and B12 for metabolic support and cellular energy.

A weekly lipotropic injection of B12, methionine, inositol, and choline to support fat metabolism and energy.

A twice-weekly NAD+ injection supporting cellular energy, DNA repair, and mitochondrial function.

A once-weekly GHRH analog injection supporting natural growth hormone production, recovery, and body composition.

Needle-free daily intranasal NAD+ for rapid absorption, cellular energy, and cognitive support.

A daily liposomal oral NAD+, encapsulated for absorption through digestion — fully needle-free.

One tablet, when you need it. A PDE5 inhibitor with apomorphine — available with sildenafil or tadalafil.

One tablet, when you need it. Two PDE5 inhibitors plus apomorphine for fast, long-lasting action.

One vial, when you need it. Three PDE5 inhibitors in a liposomal formulation for potency and rapid onset.

One vial, when you need it. Two PDE5 inhibitors plus apomorphine in a liposomal formulation.

One vial, when you need it. Three PDE5 inhibitors plus apomorphine in a liposomal formulation for high potency.